Redwood Financial Network’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,260
Closed -$204K 197
2026
Q1
$204K Buy
+7,260
New +$193K 0.13% 167
2024
Q2
Sell
-7,753
Closed -$215K 150
2024
Q1
$215K Sell
7,753
-974
-11% -$27K 0.19% 135
2023
Q4
$251K Sell
8,727
-647
-7% -$19.6K 0.24% 120
2023
Q3
$311K Sell
9,374
-4,022
-30% -$142K 0.33% 98
2023
Q2
$491K Buy
13,396
+593
+5% +$23.1K 0.46% 70
2023
Q1
$522K Buy
12,803
+486
+4% +$21K 0.53% 66
2022
Q4
$631K Sell
12,317
-23
-0.2% -$1.1K 0.72% 46
2022
Q3
$540K Buy
12,340
+35
+0.3% +$1.7K 0.62% 56
2022
Q2
$645K Sell
12,305
-824
-6% -$42K 0.7% 50
2022
Q1
$680K Buy
+13,129
New +$681K 0.63% 53

Other funds holding PFE

Redwood Financial Network's PFE Position: Q2 2026 in Review

Redwood Financial Network sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,260 shares — an estimated $204K sold.

Redwood Financial Network first reported a position in PFE in Q1 2022 and held it in 10 quarters. The position peaked at $680K in Q1 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Redwood Financial Network reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Redwood Financial Network sold 7,260 Pfizer shares in Q2 2026, an estimated $204K.
  • Redwood Financial Network first reported a position in Pfizer in Q1 2022 and held it in 10 quarters.
  • Redwood Financial Network's Pfizer position peaked at $680K in Q1 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Redwood Financial Network's 13F filing for Q2 2026, filed 7 Aug 2026.